Mental Health Clinician (Aug 2024)

Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists

  • Amber R. Douglass, PharmD, BCPS, BCPP,
  • Ashley Maister, PharmD, BCPP,
  • Karen E. Moeller, PharmD, BCPP,
  • Aaron Salwan, PharmD, MPH, BCPP,
  • Anuja Vallabh, PharmD, BCPP,
  • Kristin Waters, PharmD, BCPP, BCPS,
  • Gregory H. Payne, MBA, CAE

DOI
https://doi.org/10.9740/mhc.2024.08.253
Journal volume & issue
Vol. 14, no. 4
pp. 253 – 266

Abstract

Read online

Deaths related to opioid overdoses continue to climb, and there remains a need for innovative strategies to address this ongoing crisis. Harm reduction (HR), a nonjudgmental philosophy aimed at reducing consequences associated with drug use and other potentially unsafe behavior, has emerged as a compassionate and effective approach. Harm reduction further emphasizes overdose prevention and fosters a shift in perspective that recognizes substance use disorder as a disease and not a moral failing. The tenets of HR collectively advocate for the well-being of individuals who use substances and support any positive change as defined by the individual. Given the high rate of morbidity and mortality associated with substance misuse and barriers or ambivalence to receiving treatment, awareness of and advocacy for HR practice is essential. This manuscript aims to describe evidence-based HR interventions, provide a foundation for the implementation of services, and further promote the importance of providing humanistic care without judgment. As valued members of the multidisciplinary treatment team, Board-Certified Psychiatric Pharmacists should implement and engage in HR services in the settings where people with substance use disorders receive care.

Keywords